1. Home
  2. ACFN vs MDAI Comparison

ACFN vs MDAI Comparison

Compare ACFN & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACFN

Acorn Energy Inc.

HOLD

Current Price

$17.23

Market Cap

43.8M

ML Signal

HOLD

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.55

Market Cap

39.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACFN
MDAI
Founded
1986
2013
Country
United States
United States
Employees
26
78
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
39.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACFN
MDAI
Price
$17.23
$1.55
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
23.2K
726.9K
Earning Date
03-05-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$63.80
P/E Ratio
$6.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.42
$1.11
52 Week High
$33.00
$3.21

Technical Indicators

Market Signals
Indicator
ACFN
MDAI
Relative Strength Index (RSI) 41.20 53.48
Support Level $16.12 $1.48
Resistance Level $17.20 $1.76
Average True Range (ATR) 1.29 0.15
MACD -0.26 0.02
Stochastic Oscillator 5.38 58.44

Price Performance

Historical Comparison
ACFN
MDAI

About ACFN Acorn Energy Inc.

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: